John R Lake

Summary

Affiliation: University of Minnesota
Country: USA

Publications

  1. doi request reprint Do we really need long-term hepatitis B hyperimmune globulin? What are the alternatives?
    John R Lake
    Gastroenterology Division, University of Minnesota, Minneapolis, MN 55455, USA
    Liver Transpl 14:S23-6. 2008
  2. ncbi request reprint Differential effects of donor age in liver transplant recipients infected with hepatitis B, hepatitis C and without viral hepatitis
    John R Lake
    Gastroenterology Division, University of Minnesota, Minneapolis, Minnesota, USA
    Am J Transplant 5:549-57. 2005
  3. ncbi request reprint Split-liver transplants for two adult recipients: technique of preservation of the vena cava with the right lobe graft
    Abhinav Humar
    Department of Surgery, University of Minnesota, Minneapolis, MN 55455, USA
    Liver Transpl 10:153-5. 2004
  4. ncbi request reprint Hepatitis B prophylaxis post-liver transplant without maintenance hepatitis B immunoglobulin therapy
    Dilip S Nath
    Department of Surgery, University of Minnesota Medical School, Minneapolis, 55455, USA
    Clin Transplant 20:206-10. 2006
  5. doi request reprint Immunosuppression in HCV-positive liver-transplant recipients
    Aaron James Chan
    Department of Medicine, University of Minnesota, Minneapolis, Minnesota 55455, USA
    Curr Opin Organ Transplant 17:648-54. 2012
  6. ncbi request reprint Hepatitis B immune globulin for life versus limited use: I favor limited duration of therapy
    John R Lake
    Liver Transplantation Program, University of Minnesota, Minneapolis, MN 55455, USA
    Liver Transpl 8:S90-1. 2002
  7. doi request reprint Hot-topic debate on kidney function: renal-sparing approaches are ineffective
    John R Lake
    Division of Gastroenterology and Hepatology, University of Minnesota, Minneapolis, MN 55455, USA
    Liver Transpl 17:S50-3. 2011
  8. ncbi request reprint The role of immunosuppression in recurrence of hepatitis C
    John R Lake
    Gastroenterology Division, University of Minnesota, Minneapolis, MN 55455, USA
    Liver Transpl 9:S63-6. 2003
  9. doi request reprint Renal dysfunction in liver transplant recipients: evaluation of the critical issues
    Marc L Weber
    Divisions of Renal Diseases and Hypertension, University of Minnesota Medical Center, Minneapolis, MN 55414, USA
    Liver Transpl 18:1290-301. 2012
  10. ncbi request reprint The impact of MELD allocation on simultaneous liver-kidney transplantation
    Julie A Thompson
    Division of Gastroenterology and Hepatology, 420 Delaware Street SE MMC 36, Minneapolis, MN 55455, USA
    Curr Gastroenterol Rep 11:76-82. 2009

Collaborators

Detail Information

Publications20

  1. doi request reprint Do we really need long-term hepatitis B hyperimmune globulin? What are the alternatives?
    John R Lake
    Gastroenterology Division, University of Minnesota, Minneapolis, MN 55455, USA
    Liver Transpl 14:S23-6. 2008
    ..4. Effective prophylaxis against HBV re-infection can now be accomplished with combination nucleoside/nucleotide anti-virals...
  2. ncbi request reprint Differential effects of donor age in liver transplant recipients infected with hepatitis B, hepatitis C and without viral hepatitis
    John R Lake
    Gastroenterology Division, University of Minnesota, Minneapolis, Minnesota, USA
    Am J Transplant 5:549-57. 2005
    ..There are clear differences in risk factors for poor outcomes based on underlying liver disease, particularly with regard to the impact of donor age...
  3. ncbi request reprint Split-liver transplants for two adult recipients: technique of preservation of the vena cava with the right lobe graft
    Abhinav Humar
    Department of Surgery, University of Minnesota, Minneapolis, MN 55455, USA
    Liver Transpl 10:153-5. 2004
  4. ncbi request reprint Hepatitis B prophylaxis post-liver transplant without maintenance hepatitis B immunoglobulin therapy
    Dilip S Nath
    Department of Surgery, University of Minnesota Medical School, Minneapolis, 55455, USA
    Clin Transplant 20:206-10. 2006
    ..We examined outcomes in recipients who underwent a liver transplant for HBV-induced liver disease and received a protocol for prophylaxis that did not use HBIG maintenance...
  5. doi request reprint Immunosuppression in HCV-positive liver-transplant recipients
    Aaron James Chan
    Department of Medicine, University of Minnesota, Minneapolis, Minnesota 55455, USA
    Curr Opin Organ Transplant 17:648-54. 2012
    ..The purpose of this review is to evaluate the historical and recent literature as it pertains to current immunosuppression regimens in hepatitis C virus (HCV)-positive (+) liver-transplant recipients...
  6. ncbi request reprint Hepatitis B immune globulin for life versus limited use: I favor limited duration of therapy
    John R Lake
    Liver Transplantation Program, University of Minnesota, Minneapolis, MN 55455, USA
    Liver Transpl 8:S90-1. 2002
  7. doi request reprint Hot-topic debate on kidney function: renal-sparing approaches are ineffective
    John R Lake
    Division of Gastroenterology and Hepatology, University of Minnesota, Minneapolis, MN 55455, USA
    Liver Transpl 17:S50-3. 2011
    ..4. The use of CNIs in the early posttransplant period is currently essential. 5. Whether new agents will be able to provide effective immunosuppression as primary immunosuppressives remains to be proven...
  8. ncbi request reprint The role of immunosuppression in recurrence of hepatitis C
    John R Lake
    Gastroenterology Division, University of Minnesota, Minneapolis, MN 55455, USA
    Liver Transpl 9:S63-6. 2003
    ..3. Change in the degree of immunosuppression, rather than the absolute amount of immunosuppression, is bad for HCV-infected recipients. 4. Corticosteroid boluses are bad for HCV-infected recipients...
  9. doi request reprint Renal dysfunction in liver transplant recipients: evaluation of the critical issues
    Marc L Weber
    Divisions of Renal Diseases and Hypertension, University of Minnesota Medical Center, Minneapolis, MN 55414, USA
    Liver Transpl 18:1290-301. 2012
    ..In this review of the literature, renal dysfunction in the setting of liver transplantation is evaluated, and the critical issues that are barriers to improved outcomes are highlighted...
  10. ncbi request reprint The impact of MELD allocation on simultaneous liver-kidney transplantation
    Julie A Thompson
    Division of Gastroenterology and Hepatology, 420 Delaware Street SE MMC 36, Minneapolis, MN 55455, USA
    Curr Gastroenterol Rep 11:76-82. 2009
    ..Finally, recommendations regarding who should receive SLK transplants are reviewed...
  11. ncbi request reprint Technique of split-liver transplant for two adult recipients
    Abhinav Humar
    Department of Surgery, University of Minnesota, Minneapolis, MN 55455, USA
    Liver Transpl 8:725-9. 2002
  12. ncbi request reprint Prevention of post-transplant cardiovascular disease--report and recommendations of an ad hoc group
    Andrew D Bostom
    Department of Surgery, University of Minnesota, MMC 328 Mayo, Minneapolis 55455, USA
    Am J Transplant 2:491-500. 2002
  13. ncbi request reprint The challenging patient: HCV and alcoholic liver disease
    Michael R Lucey
    Department of Medicine, University of Wisconsin, School of Medicine and Public Health, Madison, WI, USA
    Liver Transpl 13:S87-8. 2007
  14. ncbi request reprint Mycophenolate mofetil combination therapy improves long-term outcomes after liver transplantation in patients with and without hepatitis C
    Russell H Wiesner
    Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Liver Transpl 11:750-9. 2005
    ..In conclusion, the addition of MMF at discharge to tacrolimus-based immunosuppression is associated with improved long-term outcomes after liver transplantation in patients with and without HCV...
  15. ncbi request reprint Immunosuppression and outcomes of patients transplanted for hepatitis C
    John R Lake
    J Hepatol 44:627-9. 2006
  16. ncbi request reprint Differences between Caucasian, African American, and Hispanic patients with primary biliary cirrhosis in the United States
    Marion G Peters
    University of California at San Francisco, San Francisco, CA 94143 0538, USA
    Hepatology 46:769-75. 2007
    ..However, the mean age, male-to-female ratio, and seroprevalence of AMA positivity were similar between the 2 groups...
  17. ncbi request reprint MELD--an imperfect, but thus far the best, solution to the problem of organ allocation
    John R Lake
    J Gastrointestin Liver Dis 17:5-7. 2008
  18. ncbi request reprint Liver transplantation for erythropoietic protoporphyria liver disease
    Brendan M McGuire
    Department of Medicine, University of Alabama at Birmingham, 1530 Third Avenue South, Birmingham, AL 35294 0005, USA
    Liver Transpl 11:1590-6. 2005
    ..In conclusion, the 5-year patient survival rate in patients transplanted for EPP liver disease is good, but the recurrence of EPP liver disease appears to diminish long term graft and patient survival...
  19. ncbi request reprint The survival impact of liver transplantation in the MELD era, and the future for organ allocation and distribution
    Robert S Brown
    Am J Transplant 5:203-4. 2005
  20. ncbi request reprint Role of tacrolimus in the evolution of liver transplantation
    Ronald W Busuttil
    Division of Liver and Pancreas Transplant, Department of Surgery, UCLA School of Medicine, Los Angeles, CA, USA
    Transplantation 77:S44-51. 2004
    ..In the decade since tacrolimus was approved for use in the United States, it has become a widely used immunosuppressant in the field of liver transplantation...